These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3040245

  • 1. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Girón CG, Ordónez A, Jalón JI, Barón MG.
    Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
    [Abstract] [Full Text] [Related]

  • 2. European experience with ifosfamide in non-small cell lung cancer.
    Drings P.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [Abstract] [Full Text] [Related]

  • 3. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Soh LT, Tan EH, Ang PT.
    Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
    [Abstract] [Full Text] [Related]

  • 4. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [Abstract] [Full Text] [Related]

  • 5. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 7. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 8. [Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
    Shimizu E, Kamei T, Kimura K, Mukai J, Nakamura Y, Kunishige E, Fukuta K, Tani K, Sone S, Ogura T.
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3719-23. PubMed ID: 2556971
    [Abstract] [Full Text] [Related]

  • 9. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J.
    Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
    Baldini E, Tibaldi C, Chella A, Angeletti CA, Romanini A, Andrei A, Algeri R, Silvano G, Conte PF.
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):12-5. PubMed ID: 8209271
    [Abstract] [Full Text] [Related]

  • 11. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
    Ohnoshi T, Hiraki S, Ueoka H, Tamura T, Kawahara S, Yonei T, Yamashita H, Ishii J, Tamai M, Egawa T.
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
    [Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
    Hayashi Y, Kato M, Matsuura T, Yamada Y, Adachi S, Ito G, Yamamoto K, Takeuchi T.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
    [Abstract] [Full Text] [Related]

  • 13. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M, Kiura K, Okabe K, Toki H, Kimura M.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [Abstract] [Full Text] [Related]

  • 14. [Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
    Itami S, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Fukutani H, Tabata M, Hirano A, Mizunuma N, Nakagawa K.
    Gan To Kagaku Ryoho; 1990 May; 17(5):1015-20. PubMed ID: 2159265
    [Abstract] [Full Text] [Related]

  • 15. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 May; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 16. Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
    Kris MG, Gralla RJ, Wertheim MS, Kelsen DP, O'Connell JP, Burke MT, Fiore JJ, Cibas IR, Heelan RT.
    Cancer Treat Rep; 1986 Sep; 70(9):1091-6. PubMed ID: 3527408
    [Abstract] [Full Text] [Related]

  • 17. [Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
    Gatzemeier U, Heckmayr M, Hossfeld DK, Kaukel E, Koschel G, Neuhauss R.
    Pneumologie; 1990 Feb; 44 Suppl 1():258-60. PubMed ID: 2164194
    [Abstract] [Full Text] [Related]

  • 18. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
    Setoguchi J, Sawada M, Onodera H, Sigeta M, Nakai M, Nakano K, Kanatsuna T, Kondoh M, Hotta T, Hayashi H.
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
    Fujita A, Sasaki H, Mori T, Nakajima S, Sekine K, Inoue Y, Honda R, Asakawa M, Suzuki A.
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):51-5. PubMed ID: 1846283
    [Abstract] [Full Text] [Related]

  • 20. Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
    Pohl G, Krajnik G, Malayeri R, Müller RM, Klepetko W, Eckersberger F, Schäfer-Prokop C, Pokrajac B, Schmeikal S, Maier A, Ambrosch G, Woltsche M, Minar W, Pirker R.
    Lung Cancer; 2006 Oct; 54(1):63-7. PubMed ID: 16926060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.